drugset

drugset / Trial / NCT02064673

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

NCT02064673 ↗

Phase 3 Recruiting 650 enrolled yair lotan

RandomizedSingle-groupDouble-blindTreatment

Summary

This is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival.

Timeline

Start: 2014-05
Primary completion: 2028-06
Completion: 2028-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Curcumin	Small molecule	500 mg	Oral

Indications